Clinical Trials Browser

Phase 2 × dinutuximab × Sarcoma × Clear all

NCT02484443 2023-10-26

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

Phase 2 Completed

41 enrolled 15 charts

Osteosarcoma